Publication | Open Access

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

Cancer ImmunosurveillanceMedicineBiological ChangesMelanomaImmunologyTumor ImmunityIpilimumab TreatmentImmune Checkpoint InhibitorDermatologyImmunotherapyOncologyAdvanced MelanomaTumor MicroenvironmentTumor BiologySkin Cancer